tadalafil has been researched along with Cancer of Kidney in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abassi, Z; Awad, H; Hussein, O; Khamaisi, M; Lahoud, Y; Matar, I; Nativ, O; Shalabi, A | 1 |
1 trial(s) available for tadalafil and Cancer of Kidney
| Article | Year |
|---|---|
Effects of phosphodiesterase-5 inhibitor on ischemic kidney injury during nephron sparing surgery: quantitative assessment by NGAL and KIM-1.
Topics: Acute Kidney Injury; Acute-Phase Proteins; Adult; Aged; Aged, 80 and over; Biomarkers; Carcinoma; Creatinine; Female; Hepatitis A Virus Cellular Receptor 1; Humans; Ischemia; Kidney Neoplasms; Lipocalin-2; Lipocalins; Male; Membrane Glycoproteins; Middle Aged; Nephrectomy; Nephrons; Phosphodiesterase 5 Inhibitors; Prospective Studies; Proto-Oncogene Proteins; Receptors, Virus; Tadalafil | 2015 |